BHI Migraine NDC 62795-1019

NDC codes

FDA NDC Directory

Product NDC (as listed)62795-1019Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62795-1019Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62795-1019-3	62795101903	1 BOTTLE in 1 CARTON (62795-1019-3) / 100 TABLET in 1 BOTTLEMarketed from Jan 1, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): BHI Migraine
Generic name (nonproprietary): acetic acid, araneus diadematus, asafetida, bryonia alba whole, tribasic calcium phosphate, activated charcoal, cinchona officinalis bark, marsdenia condurango bark, tubocurarine chloride, kalmia latifolia leaf, lycopodium clavatum spore, sodium sulfate, phosphoric acid, pulsatilla vulgaris, claviceps purpurea sclerotium, and silicon dioxide
Active ingredients: Acetic acid — 6 [hp_X]/1Araneus diadematus — 8 [hp_X]/1Asafetida — 6 [hp_X]/1Bryonia alba whole — 30 [hp_X]/1Tribasic calcium phosphate — 10 [hp_X]/1Activated charcoal — 10 [hp_X]/1Cinchona officinalis bark — 4 [hp_X]/1Marsdenia condurango bark — 4 [hp_X]/1Tubocurarine chloride — 10 [hp_X]/1Kalmia latifolia leaf — 8 [hp_X]/1Lycopodium clavatum spore — 6 [hp_X]/1Sodium sulfate — 6 [hp_X]/1Phosphoric acid — 6 [hp_X]/1Pulsatilla vulgaris — 4 [hp_X]/1Claviceps purpurea sclerotium — 6 [hp_X]/1Silicon dioxide — 10 [hp_X]/1Strychnine nitrate — 8 [hp_X]/1
Dosage form: Tablet
Route: Oral
Labeler: MediNatura Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jan 1, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 62795-1019_28fb3178-9aac-406f-a82a-de53d0876f67SPL ID 28fb3178-9aac-406f-a82a-de53d0876f67SPL set ID 11cad8ba-6914-420e-bab0-4ca37d33f2e6UNII Q40Q9N063P, 6T6CO7R3Z5, W9FZA51AS1, 56K0VVT47P, 91D9GV0Z28, 2P3VWU3H10, S003A158SB, 900961Z8VR, 79N6542N18, C88X29Y479, 0YPR65R21J, E4GA8884NN, I76KB35JEV, 01G9XEA93N, ETJ7Z6XBU4, O642E96711
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462795101903 followed by a unit qualifier and the quantity

Package 62795-1019-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 28, 2023.

Indications (excerpt from the label)

USES For the temporary relief of minor migraine headache pain, headache pain with nausea, headache due to simple nervous tension

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)